NuCana plc (NCNA) stock
NCNANasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.93−0.01 (-1.06%)
Close on Nov 12, 2026Market cap $3.87MP/E –Yield –
NuCana enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
NuCana's enterprise value was -$23.97M on Nov 10, 2026, against -$11.11M a year earlier. Over the last 5 years it ranged from -$45.48M to $24.78M, with a median of -$11.28M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 10, 2026 | -$23.97M | – |
| 2025 | Dec 31, 2025 | -$11.30M | – |
| 2024 | Dec 31, 2024 | -$12.07M | – |
| 2023 | Dec 29, 2023 | -$15.94M | – |
| 2022 | Dec 30, 2022 | -$21.84M | – |
| 2021 | Dec 31, 2021 | -$5.73M | -175.3% |
| 2020 | Dec 31, 2020 | $7.60M | -93.6% |
| 2019 | Dec 31, 2019 | $117.95M | -57.6% |
| 2018 | Dec 31, 2018 | $278.00M | +28.3% |
| 2017 | Dec 29, 2017 | $216.68M | – |
See a number that looks wrong?